Financial News
All
Basic Materials
Communication Services
Consumer Cyclical
Consumer Defensive
Energy
Financial Services
Healthcare
Industrials
Real Estate
Technology
Utilities
Macro
All Sentiment
Bullish
Neutral
Bearish
3,907 articles
📰
Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know
In the most recent trading session, Amgen (AMGN) closed at $353.93, indicating a +1.58% shift from the previous trading day.
📰
Adma Biologics (ADMA) Stock Slides as Market Rises: Facts to Know Before You Trade
Adma Biologics (ADMA) closed the most recent trading day at $9.63, moving 15% from the previous trading session.
📰
Eli Lilly (LLY) Outpaces Stock Market Gains: What You Should Know
The latest trading day saw Eli Lilly (LLY) settling at $916.31, representing a +1.47% change from its previous close.
📰
Johnson & Johnson (JNJ) Surpasses Market Returns: Some Facts Worth Knowing
Johnson & Johnson (JNJ) closed the most recent trading day at $239.93, moving +1.98% from the previous trading session.
📰
Bristol Myers Squibb (BMY) Surpasses Market Returns: Some Facts Worth Knowing
In the closing of the recent trading day, Bristol Myers Squibb (BMY) stood at $58.94, denoting a +2.7% move from the preceding trading day.
📰
Novo Nordisk (NVO) Stock Slides as Market Rises: Facts to Know Before You Trade
Novo Nordisk (NVO) closed the most recent trading day at $36.33, moving 1.52% from the previous trading session.
📰
Precigen, Inc. (PGEN) Reports Q4 Loss, Lags Revenue Estimates
Precigen (PGEN) delivered earnings and revenue surprises of +89.47% and -17.45%, respectively, for the quarter ended December 2025. Do the numbers...
📰
Precigen, Inc. (PGEN) Reports Q4 Loss, Lags Revenue Estimates
Precigen (PGEN) delivered earnings and revenue surprises of +89.47% and -17.45%, respectively, for the quarter ended December 2025. Do the numbers...
Atossa Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides a Corporate Update
SEATTLE, March 25, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (NASDAQ:ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company...
Atossa Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides a Corporate Update
SEATTLE, March 25, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company...
📰
Prediction: 2 Stocks That Will Be Worth More Than Summit Therapeutics 1 Year From Now
The next 10 months might be challenging for this biotech.
📰
Prediction: 2 Stocks That Will Be Worth More Than Summit Therapeutics 1 Year From Now
The next 10 months might be challenging for this biotech.
📰
Prediction: 2 Stocks That Will Be Worth More Than Summit Therapeutics 1 Year From Now
The next 10 months might be challenging for this biotech.
📰
Precigen (PGEN) Q4 2025 Earnings Call Transcript
Image source: The Motley Fool.Wednesday, March 25, 2026 at 4:30 p.m. ETNeed a quote from a Motley Fool analyst? Email pr@fool.comContinue reading
12 Communication Services Stocks Moving In Wednesday's After-Market Session
Gainers
Beasley Broadcast Group (NASDAQ:BBGI) shares moved upwards by 10.8% to $4.09 during Wednesday's after-market session. The market value...
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers
Healthcare Triangle (NASDAQ:HCTI) stock increased by 41.1% to $4.12 during Wednesday's after-market session. The company's market...
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers
Healthcare Triangle (NASDAQ:HCTI) stock increased by 41.1% to $4.12 during Wednesday's after-market session. The company's market...
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers
Healthcare Triangle (NASDAQ:HCTI) stock increased by 41.1% to $4.12 during Wednesday's after-market session. The company's market...
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers
Healthcare Triangle (NASDAQ:HCTI) stock increased by 41.1% to $4.12 during Wednesday's after-market session. The company's market...
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers
Healthcare Triangle (NASDAQ:HCTI) stock increased by 41.1% to $4.12 during Wednesday's after-market session. The company's market...
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers
Healthcare Triangle (NASDAQ:HCTI) stock increased by 41.1% to $4.12 during Wednesday's after-market session. The company's market...
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers
Healthcare Triangle (NASDAQ:HCTI) stock increased by 41.1% to $4.12 during Wednesday's after-market session. The company's market...
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers
Healthcare Triangle (NASDAQ:HCTI) stock increased by 41.1% to $4.12 during Wednesday's after-market session. The company's market...
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers
Healthcare Triangle (NASDAQ:HCTI) stock increased by 41.1% to $4.12 during Wednesday's after-market session. The company's market...
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers
Healthcare Triangle (NASDAQ:HCTI) stock increased by 41.1% to $4.12 during Wednesday's after-market session. The company's market...
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers
Healthcare Triangle (NASDAQ:HCTI) stock increased by 41.1% to $4.12 during Wednesday's after-market session. The company's market...
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers
Healthcare Triangle (NASDAQ:HCTI) stock increased by 41.1% to $4.12 during Wednesday's after-market session. The company's market...
📰
Top Stock Reports for Amazon.com, TJX and Eaton Corp.
Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), The TJX Companies, Inc. (TJX) and Eaton...
📰
Rani Therapeutics Appoints Jesper Høiland as Head of Strategy to Advance Corporate and Pipeline Prioritization
SAN JOSE, Calif., March 25, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. ("Rani Therapeutics" or "Rani") (NASDAQ:RANI), a...
📰
Rani Therapeutics Appoints Jesper Høiland as Head of Strategy to Advance Corporate and Pipeline Prioritization
SAN JOSE, Calif., March 25, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a...
📰
Dyadic Announces 2025 Financial Results and Highlights Recent Company Progress
Commercial launch of AlbuFree™ DX recombinant human albumin by Proliant Health & Biologicals using Dyadic's production platform, with...
📰
Dyadic Announces 2025 Financial Results and Highlights Recent Company Progress
DYADIC ANNOUNCES 2025 FINANCIAL RESULTS AND HIGHLIGHTS RECENT COMPANY PROGRESS
TELA Bio Analysts Cut Their Forecasts After Q4 Results
TELA Bio, Inc. (NASDAQ:TELA) reported mixed results for the fourth quarter on Tuesday.
The company posted quarterly losses of 17 cents per share...
📰
Why Investors Strapped a Rocket to Corcept Therapeutics Stock on Wednesday
A top regulator approved one of its drugs that afternoon.
📰
NMRA Investors Have Opportunity to Join Neumora Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES, March 25, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is...
📰
Planet 13 Announces Q4 2025 Financial Results
●
Q4 2025 Revenue of $25.2 million
●
Q4 2025 Net loss of $4.6 million
●
Q4 2025 Adjusted EBITDA loss of $0.3 million
All results...
Innovative Eyewear Inc. Reports Full Year 2025 Financial Results
Revenue increased 63% over prior year
Gross Profit Margins increased by 8 percentage points despite tariff headwinds
MIAMI, March 25, 2026...
Innovative Eyewear Inc. Reports Full Year 2025 Financial Results
Revenue increased 63% over prior year
Gross Profit Margins increased by 8 percentage points despite tariff headwinds
MIAMI, March 25, 2026...
📰
Planet 13 Announces Q4 2025 Financial Results
All results are reported in United States dollars ($) unless otherwise indicated.
📰
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Atara Biotherapeutics, Inc. (ATRA)
NEW YORK, March 25, 2026 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the...